Hyperthyroidism in pregnancy

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 19, Issue 5, 2012, Pages 394-401

  Mestman, Jorge H ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

antithyroid drug therapy; fetal neonatal thyroid dysfunction; gestational hyperthyroidism; hyperthyroidism; pregnancy

Indexed keywords

ANTITHYROID AGENT; THYROTROPIN;

ABLATION THERAPY; DRUG TOLERABILITY; FETUS DEVELOPMENT; FIRST TRIMESTER PREGNANCY; GRAVES DISEASE; HUMAN; HYPEREMESIS GRAVIDARUM; HYPERTHYROIDISM; LACTATION; PATIENT COUNSELING; PRACTICE GUIDELINE; PREGNANCY; PUERPERIUM; REVIEW; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL;

ANTITHYROID AGENTS; DIAGNOSIS, DIFFERENTIAL; DIRECTIVE COUNSELING; DISEASE MANAGEMENT; FEMALE; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; INFANT, NEWBORN; LACTATION; MATERNAL-CHILD HEALTH CENTERS; POSTNATAL CARE; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PRENATAL DIAGNOSIS; THYROID FUNCTION TESTS; THYROTOXICOSIS;

EID: 84865987409     PISSN: 1752296X     EISSN: 17522978     Source Type: Journal    
DOI: 10.1097/MED.0b013e328357f3d5     Document Type: Review

References (44)

1. Marx H, Amin P, Lazarus JH. Hyperthyroidism and pregnancy. BMJ 2008; 336:663-667.
2. Patil-Sisodia K, Mestman JH. Graves' hyperthyroidism and pregnancy: a clinical update. Endocr Pract 2010; 16:118-129.
3. Stagnaro-Green A, Abalovich M, Alexander E, et al. 2011 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and Postpartum. Thyroid 2011; 21:1081-1125.
4. De Groot L, Abalovich M, Alexander EK, et al. Endocrine Society Guidelines on Management of Thyroid Disease during Pregnancy and Postpartum. J Clin Endocr Metab 2012; 97: 2543-2565.
5. Lazarus J. Pre-conception counseling in Graves' disease. Eur Thyroid J 2012; 1:24-29.
6. Laurberg P, Wallin G, Tallstedt L, et al. TSH receptor autoimmunity in Graves' disease after therapy with antithyroid drugs, surgery, or radioiodine: a 5 year prospective randomized study. Eur J Endocrinol 2008; 158:69-75.
7. Tamaki H, Itoh E, Kaneda T, et al. Crucial role of serum human chorionic gonadotropin for the aggravation of thyrotoxicosis in early pregnancy in Graves' disease. Thyroid 1993; 3:189-193.
8. Tagami T, Hagiwara H, Kimura T, et al. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease. Thyroid 2007; 17:767-772.
9. Rotondi M, Cappelli C, Pirali B, et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008; 93:3985-3988.
10. Yassa L, Marqusee E, Fawcett R, et al. Thyroid hormone early adjustment in pregnancy: the THERAPY trial. J Clin Endocrinol Metab 2010; 95:3234.
11. Abalovich M, Alcaraz G, Kleiman-Rubinsztein J, et al. The relationship of preconception thyrotropin levels to requirements for increasing the levothyroxine dose during pregnancy in women with primary hypothyroidism. Thyroid 2010; 20:1175.
12. Lauberg P, Bournaud C, Karmmisholt J, et al. Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009; 160:1-8.
13. McNab T, Ginsberg J. Use of antithyroid drugs in euthyroid patient women with previous Graves' disease. Clin Invest Med 2005; 28:127-131.
14. Kopp P, Van Sande J, Parma J, et al. Brief report: congenital hyperthyroidism caused by a mutation in the thyrotropin receptor gene. N Engl J Med 1995; 322:150-154.
15. De Roux N, Polak M, Coet J. A neomutation of thyroid stimulating hormone receptor in severe neonatal hyperthyroidism. J Clin Endocrinol Metab 1996; 81:2023-2026.
16. Goldman A, Mestman JH. Transient nonimmune hyperthyroidism of early pregnancy. J Thyroid Res 2011; 142413.
17. Goodwin TM, Montoro MN, Mestman JH. Transient hyperthyroidism and hyperemesis gravidarum: clinical aspects. Am J Obstet Gynecol 1992; 167:648.
18. Tan JYI, Loh KC, Yeo GSH, et al. Transient hyperthyroidism of hyperemesis gravidarum. BJOG 2002; 109:683-688.
19. Zhang Y, Cantor RM, MacGibbon K, et al. Familial aggression of hyperemesis gravidarum. Am J Obstet Gynecol 2011; 204:230.e1-230.e7.
20. Grun JP, Meuris S, De Nayer P, et al. The thyrotrophic role of human chorionic gonadotropin (hCG) in the early stages of twin (versus single) pregnancies. Clin Endocrinol 1997; 46:719.
21. Hershman JH. Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab 2004; 18:267-288.
22. Davis LE, Lucas MJ, Hankins GDV, et al. Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1988; 160:63.
23. Millar LK, Wing DA, Leung AS, et al. Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994; 84:946-949.
24. Phoojaroenchanachai M, Sriussadaporn S, Peerapatdit T, et al. Effect of maternal hyperthyroidism during late pregnancy on the risk of neonatal low birth weight. Clin Endocrinol 2001; 54:365-370.
25. Mestman JH. Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 2004; 18:267-288.
26. Kung AWC, Jones BM. A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy. J Clin Endocrinol Metab 1998; 83:514-518.
27. Weetman AP. Immunity, thyroid function and pregnancy: molecular mechanisms. Nat Rev Endocrinol 2010; 6:311-318.
28. Amino N, Izumi Y, Hidaka Y, et al. No increase of blocking type antithyrotropin receptor antibodies during pregnancy in patients with Graves' disease. J Clin Endocrinol Metab 2003; 88:5871-5874.
29. Momotani N, Noh J, Oyangi H, et al. Antithyroid during therapy for Graves' disease during pregnancy: optimal regimen for fetal thyroid status. N Engl J Med 1986; 315:24-28.
30. Zimmerman D. Fetal and neonatal hyperthyroidism. Thyroid 1999; 9:727-733.
31. Sheffield JS, Cunningham FG. Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol 2004; 190:211-217.
32. Chonh HW, See KC, Phua J. Thyroid storm with multiorgan failure. Thyroid 2010; 20:333-336; 29.
33. Luton D, LeGac I, Vullard E, et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005; 90:6093-6098.
34. Nachum Z, Rakover Y, Weiner E, Shalev E. Graves' disease in pregnancy: prospective evaluation of a selective invasive treatment protocol. Am J Obstet Gynecol 2003; 189:159-165.
35. Davidson KM, Richards DS, Schatz DA, Fisher DA. Successful in utero treatment of fetal goiter and hypothyroidism. N Engl J Med 1991; 324: 543-546.
36. McKenzie JM, Zakarija M. Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies. Thyroid 1992; 2:155-159.
37. Peleg D, Cada S, Peleg A, Ben-Ami M. The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis. Obstet Gynecol 2002; 99:1040-1043.
38. Mortimer RH, Tyack SA, Galligan JP, et al. Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. Clin Endocrinol (Oxf) 1990; 32:141-152.
39. Papendieck P, Chiesa A, Prieto L, et al. Thyroid disorders of neonates born to mothers with Graves disease. J Pediatr Endocrinol Metab 2009; 22:547-553.
40. Momotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation of the offspring. Clin Endocrinol 1984; 20:695.
41. Ishikawa N. The relationship between neonatal developmental dysplasia of the hip and maternal hyperthyroidism. J Pediatr Orthop 2008; 28:432-434.
42. Kempers MJE, van Trotsenburg ASP, van Rijn RR, et al. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease. J Clin Endocrinol Metab 2007; 92:2984-2991.
43. Karras S, Tzotzas T, Kaltsas T, Krassas GE. Pharmacological treatment of hyperthyroidism during lactation: review of the literature and novel data. Pediatr Endocrinol Rev 2010; 8:25-33.
44. Azizi F, Bahrainian M, Khamsch ME, et al. Intellectual development and thyroid function in children who were breastfed by thyrotoxic mothers taking methimazole. J Pediatr Endocrinol Metab 2003; 16:1239-1243.